Parashos, Sotirios A <br/><br/>
Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.  [electronic resource] 

 -  Archives of neurology  Sep 2009 
 - 1099-104 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-3687 
<br/><br/><label>Standard No.: </label>10.1001/archneurol.2009.159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living--psychology<br/>Adult<br/>Aged<br/>Antiparkinson Agents--administration & dosage<br/>Creatine--administration & dosage<br/>Disability Evaluation<br/>Disease Management<br/>Drug Administration Schedule<br/>Endpoint Determination--methods<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Minocycline--administration & dosage<br/>Mobility Limitation<br/>Neuropsychological Tests<br/>Parkinson Disease--diagnosis<br/>Predictive Value of Tests<br/>Severity of Illness Index<br/>Surveys and Questionnaires<br/>Tacrolimus--administration & dosage<br/>Time Factors<br/>Ubiquinone--administration & dosage